who created glp 1 should win a Nobel for the science of the Ozempic revolution? Discovery of GLP-1–Based Drugs for

Originally developed for diabetes and now widely used for weight management industries are buzzing on what it means for them, especially healthcare and closer to home with the life insurance industry

They work by signalling skin cells to perform specific functions such as: collagen production wound healing and hydration

Edinburgh University Press

With this in mind, DPP-4 inhibitors represent a good choice for patients with high cardiovascular risk, but they are not a first-line consideration for cardiovascular protection compared to SGLT2 inhibitors or glucagon-like peptide-1 receptor agonists, which showed greater CV benefits [35], [27]

Armonk, IBM Corp